2m 2m 2m 2m 2m 2m 2m
PHATHOM PHARMA (PHAT)
NASDAQ
$8.86-$0.010 (-0.11%)
Price as of Aug 21, 2026 7:34 PM EDT- $717.6MMarket Cap
- -25.52%1-Year Change
- BiotechnologyIndustry
PHATHOM PHARMA (PHAT)
$8.86-$0.010 (-0.11%)
Earnings Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 0 | ||
Growth | 1 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 1.75% | ||
12-Month Momentum | 5.94% | ||
3-Month Risk Adjusted Momentum | 7.04% | ||
12-Month Risk Adjusted Momentum | 10.11% |
True Yield
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.03% | ||
Net Debt Paydown Yield | -0.10% |
Financial Health Score
Valuation | PHAT | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 5 |